Nilsine Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Nilsine Partners's MRK Position: Q3 2026 in Review
Nilsine Partners reduced its Merck (MRK) stake by 2.3% in Q3 2026, selling an estimated $83K and leaving 25,543 shares worth $3.71M. The position accounts for 0.26% of the portfolio, ranked #93.
Nilsine Partners first reported a position in MRK in Q1 2023 and has held it in 15 quarters since. 3,967 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Nilsine Partners held 25,543 shares of Merck worth $3.71M as of Q3 2026.
- Nilsine Partners sold 601 Merck shares in Q3 2026, an estimated $83K.
- Merck made up 0.26% of Nilsine Partners's portfolio in Q3 2026, its #93 holding.
- Nilsine Partners first reported a position in Merck in Q1 2023 and has held it in 15 quarters since.
- 3,967 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.